Named after engineer, military leader and public administrator Sir John Monash, Monash University was established by an Act of Parliament in 1958. Since the first students began their studies at the university’s foundation campus in 1961, Monash has grown to become Australia’s largest university.
Monash is the youngest member of the Group of Eight, the coalition of Australia’s most prestigious researchintensive universities. The university’s youthfulness shows through in the way it approaches education and research.
It isn’t wedded to convention, which means students are offered a first-class education while being encouraged to become agents of change.
Indeed, the concept of transformation lies at the heart of the Monash philosophy. For students, researchers and staff, that philosophy is not only about transforming their own lives but also making a difference to the lives of others.
With more than 250,000 graduates across the world, campuses in Malaysia and South Africa, an education and research centre in Italy and a joint-research academy in India, Monash is a global university with the ambition and ability to address momentous global challenges.
Significant research breakthroughs:
Monash researchers have been leaders in areas like IVF and reproduction, road safety, malaria and influenza treatment, and stem cells for many years, and in some cases, decades.
In the last twenty years alone, Monash researchers have:
• Designed and synthesised a drug which would be released as the breakthough anti-flu pharmaceutical product, Relenza in 1999.
• Developed a single, oral-dose cure for malaria, effective in laboratory conditions (2004). Today, the new drug is in the second phase of clinical trials on humans and promises to be cheap, easy to manufacture and quick to administer.
• Worked out how to deactivate the digestive enzyme in our bodies used by the malarial parasite to sustain itself (2009). This discovery is also being used to develop drugs to treat malaria.
• Discovered a potential new treatment for breast cancer (2010). Over four years, their research team analysed more than 400 human breast cancer tissue samples. They found that more aggressive breast tumours were less likely to be accompanied by the presence of a protein known as INPP4B. They then created an antibody to INPP4B, which easily detects the protein in biopsies.
• Demonstrated that nerve stem cells could be derived from human embryonic stem cells in the laboratory (2000). They later showed that, outside of the laboratory, human embryonic stem cells could develop into nerve cells, raising the revolutionary prospect of treating a range of diseases from Parkinson's through to Alzheimer's and diabetes.
Monash is ranked:
The Times Higher Education World University Rankings (2012-2013) rates us:
The QS World University Rankings by Subject (2013) rates Monash:
The Academic Ranking of World Universities (2012) rates us: